Selected research
Market Structure
Global Diammonium Glycyrrhizinate Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Diammonium Glycyrrhizinate Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Diammonium Glycyrrhizinate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Diammonium Glycyrrhizinate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diammonium Glycyrrhizinate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Diammonium Glycyrrhizinate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Diammonium Glycyrrhizinate Capsules include Chia Tai Tianqing Pharmaceutical, Suzhou Erye Pharmaceutical, Sichuan Shenghe Pharmaceutical, Shanxi Tongda Pharmaceutical and China Resources Double-Crane Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Diammonium Glycyrrhizinate Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Diammonium Glycyrrhizinate Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Diammonium Glycyrrhizinate Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diammonium Glycyrrhizinate Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Diammonium Glycyrrhizinate Capsules Segment by Company
Chia Tai Tianqing Pharmaceutical
Suzhou Erye Pharmaceutical
Sichuan Shenghe Pharmaceutical
Shanxi Tongda Pharmaceutical
China Resources Double-Crane Pharmaceutical
Diammonium Glycyrrhizinate Capsules Segment by Type
Original Drug
Generic Drug
Diammonium Glycyrrhizinate Capsules Segment by Application
Hospital
Clinic
Others
Diammonium Glycyrrhizinate Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diammonium Glycyrrhizinate Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diammonium Glycyrrhizinate Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diammonium Glycyrrhizinate Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Diammonium Glycyrrhizinate Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diammonium Glycyrrhizinate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diammonium Glycyrrhizinate Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Diammonium Glycyrrhizinate Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drug
- Generic Drug
Applications
- Hospital
- Clinic
- Others
Companies covered
- Chia Tai Tianqing Pharmaceutical
- Suzhou Erye Pharmaceutical
- Sichuan Shenghe Pharmaceutical
- Shanxi Tongda Pharmaceutical
- China Resources Double-Crane Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Diammonium Glycyrrhizinate Capsules Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Diammonium Glycyrrhizinate Capsules Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Diammonium Glycyrrhizinate Capsules Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Diammonium Glycyrrhizinate Capsules Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Diammonium Glycyrrhizinate Capsules Market Dynamics
- 2.1 Diammonium Glycyrrhizinate Capsules Industry Trends
- 2.2 Diammonium Glycyrrhizinate Capsules Industry Drivers
- 2.3 Diammonium Glycyrrhizinate Capsules Industry Opportunities and Challenges
- 2.4 Diammonium Glycyrrhizinate Capsules Industry Restraints
3 Diammonium Glycyrrhizinate Capsules Market by Manufacturers
- 3.1 Global Diammonium Glycyrrhizinate Capsules Revenue by Manufacturers (2021-2026)
- 3.2 Global Diammonium Glycyrrhizinate Capsules Sales by Manufacturers (2021-2026)
- 3.3 Global Diammonium Glycyrrhizinate Capsules Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Diammonium Glycyrrhizinate Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Diammonium Glycyrrhizinate Capsules Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Diammonium Glycyrrhizinate Capsules Manufacturers, Product Type & Application
- 3.7 Global Diammonium Glycyrrhizinate Capsules Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Diammonium Glycyrrhizinate Capsules Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Diammonium Glycyrrhizinate Capsules Players Market Share by Revenue in 2025
- 3.8.3 2025 Diammonium Glycyrrhizinate Capsules Tier 1, Tier 2, and Tier 3
4 Diammonium Glycyrrhizinate Capsules Market by Type
- 4.1 Diammonium Glycyrrhizinate Capsules Type Introduction
- 4.1.1 Original Drug
- 4.1.2 Generic Drug
- 4.2 Global Diammonium Glycyrrhizinate Capsules Sales by Type
- 4.2.1 Global Diammonium Glycyrrhizinate Capsules Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Diammonium Glycyrrhizinate Capsules Sales by Type (2021-2032)
- 4.2.3 Global Diammonium Glycyrrhizinate Capsules Sales Market Share by Type (2021-2032)
- 4.3 Global Diammonium Glycyrrhizinate Capsules Revenue by Type
- 4.3.1 Global Diammonium Glycyrrhizinate Capsules Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Diammonium Glycyrrhizinate Capsules Revenue by Type (2021-2032)
- 4.3.3 Global Diammonium Glycyrrhizinate Capsules Revenue Market Share by Type (2021-2032)
5 Diammonium Glycyrrhizinate Capsules Market by Application
- 5.1 Diammonium Glycyrrhizinate Capsules Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Diammonium Glycyrrhizinate Capsules Sales by Application
- 5.2.1 Global Diammonium Glycyrrhizinate Capsules Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Diammonium Glycyrrhizinate Capsules Sales by Application (2021-2032)
- 5.2.3 Global Diammonium Glycyrrhizinate Capsules Sales Market Share by Application (2021-2032)
- 5.3 Global Diammonium Glycyrrhizinate Capsules Revenue by Application
- 5.3.1 Global Diammonium Glycyrrhizinate Capsules Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Diammonium Glycyrrhizinate Capsules Revenue by Application (2021-2032)
- 5.3.3 Global Diammonium Glycyrrhizinate Capsules Revenue Market Share by Application (2021-2032)
6 Global Diammonium Glycyrrhizinate Capsules Sales by Region
- 6.1 Global Diammonium Glycyrrhizinate Capsules Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Diammonium Glycyrrhizinate Capsules Sales by Region (2021-2032)
- 6.2.1 Global Diammonium Glycyrrhizinate Capsules Sales by Region (2021-2026)
- 6.2.2 Global Diammonium Glycyrrhizinate Capsules Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Diammonium Glycyrrhizinate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Diammonium Glycyrrhizinate Capsules Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Diammonium Glycyrrhizinate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Diammonium Glycyrrhizinate Capsules Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Diammonium Glycyrrhizinate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Diammonium Glycyrrhizinate Capsules Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Diammonium Glycyrrhizinate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Diammonium Glycyrrhizinate Capsules Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Diammonium Glycyrrhizinate Capsules Revenue by Region
- 7.1 Global Diammonium Glycyrrhizinate Capsules Revenue by Region
- 7.1.1 Global Diammonium Glycyrrhizinate Capsules Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Diammonium Glycyrrhizinate Capsules Revenue by Region (2021-2026)
- 7.1.3 Global Diammonium Glycyrrhizinate Capsules Revenue by Region (2027-2032)
- 7.1.4 Global Diammonium Glycyrrhizinate Capsules Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Diammonium Glycyrrhizinate Capsules Revenue (2021-2032)
- 7.2.2 North America Diammonium Glycyrrhizinate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Diammonium Glycyrrhizinate Capsules Revenue (2021-2032)
- 7.3.2 Europe Diammonium Glycyrrhizinate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Diammonium Glycyrrhizinate Capsules Revenue (2021-2032)
- 7.4.2 Asia-Pacific Diammonium Glycyrrhizinate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Diammonium Glycyrrhizinate Capsules Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Diammonium Glycyrrhizinate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Chia Tai Tianqing Pharmaceutical
- 8.1.1 Chia Tai Tianqing Pharmaceutical Company Information
- 8.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 8.1.3 Chia Tai Tianqing Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Chia Tai Tianqing Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
- 8.2 Suzhou Erye Pharmaceutical
- 8.2.1 Suzhou Erye Pharmaceutical Company Information
- 8.2.2 Suzhou Erye Pharmaceutical Business Overview
- 8.2.3 Suzhou Erye Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Suzhou Erye Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.2.5 Suzhou Erye Pharmaceutical Recent Developments
- 8.3 Sichuan Shenghe Pharmaceutical
- 8.3.1 Sichuan Shenghe Pharmaceutical Company Information
- 8.3.2 Sichuan Shenghe Pharmaceutical Business Overview
- 8.3.3 Sichuan Shenghe Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sichuan Shenghe Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.3.5 Sichuan Shenghe Pharmaceutical Recent Developments
- 8.4 Shanxi Tongda Pharmaceutical
- 8.4.1 Shanxi Tongda Pharmaceutical Company Information
- 8.4.2 Shanxi Tongda Pharmaceutical Business Overview
- 8.4.3 Shanxi Tongda Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanxi Tongda Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.4.5 Shanxi Tongda Pharmaceutical Recent Developments
- 8.5 China Resources Double-Crane Pharmaceutical
- 8.5.1 China Resources Double-Crane Pharmaceutical Company Information
- 8.5.2 China Resources Double-Crane Pharmaceutical Business Overview
- 8.5.3 China Resources Double-Crane Pharmaceutical Diammonium Glycyrrhizinate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 China Resources Double-Crane Pharmaceutical Diammonium Glycyrrhizinate Capsules Product Portfolio
- 8.5.5 China Resources Double-Crane Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Diammonium Glycyrrhizinate Capsules Value Chain Analysis
- 9.1.1 Diammonium Glycyrrhizinate Capsules Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Diammonium Glycyrrhizinate Capsules Production Mode & Process
- 9.2 Diammonium Glycyrrhizinate Capsules Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Diammonium Glycyrrhizinate Capsules Distributors
- 9.2.3 Diammonium Glycyrrhizinate Capsules Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst